Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Joji Suzuki, M.D.

Title
Institution
Department
Address
Phone

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. K23DA042326 (SUZUKI, JOJI) Aug 15, 2017 - Jul 31, 2022
    NIH/NIDA
    Initiating substance use disorder treatment in hospitalized opioid use disorder patients
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Suzuki J, Garayalde S, Dodoo M, Rodriguez C. Psychiatry residents' and fellows' confidence and knowledge in interpreting urine drug testing results related to opioids. Subst Abus. 2018; 39(4):518-521. PMID: 29697313.
    Citations:    Fields:    
  2. Weiner SG, Price CN, Atalay AJ, Harry EM, Pabo EA, Patel R, Suzuki J, Anderson S, Ashley SW, Kachalia A. A Health System-Wide Initiative to Decrease Opioid-Related Morbidity and Mortality. Jt Comm J Qual Patient Saf. 2019 01; 45(1):3-13. PMID: 30166254.
    Citations:    Fields:    
  3. Suzuki J, Johnson J, Montgomery M, Hayden M, Price C. Outpatient Parenteral Antimicrobial Therapy Among People Who Inject Drugs: A Review of the Literature. Open Forum Infect Dis. 2018 Sep; 5(9):ofy194. PMID: 30211247.
    Citations:    
  4. Braun IM, Wright A, Peteet J, Meyer FL, Yuppa DP, Bolcic-Jankovic D, LeBlanc J, Chang Y, Yu L, Nayak MM, Tulsky JA, Suzuki J, Nabati L, Campbell EG. Medical Oncologists' Beliefs, Practices, and Knowledge Regarding Marijuana Used Therapeutically: A Nationally Representative Survey Study. J Clin Oncol. 2018 Jul 01; 36(19):1957-1962. PMID: 29746226.
    Citations: 1     Fields:    
  5. Friedmann PD, Suzuki J. More beds are not the answer: transforming detoxification units into medication induction centers to address the opioid epidemic. Addict Sci Clin Pract. 2017 11 15; 12(1):29. PMID: 29141667.
    Citations:    Fields:    Translation:Humans
  6. Suzuki J, Zinser J, Issa M, Rodriguez C. Quantitative testing of buprenorphine and norbuprenorphine to identify urine sample spiking during office-based opioid treatment. Subst Abus. 2017 Oct-Dec; 38(4):504-507. PMID: 28723256.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  7. Twark C, Suzuki J. Fenethylline-Induced Psychosis, Fenethylline-Themed Paranoid Delusions, or Both? Psychosomatics. 2017 Sep - Oct; 58(5):561-564. PMID: 28577859.
    Citations:    Fields:    Translation:Humans
  8. Braun IM, Meyer FL, Gagne JJ, Nabati L, Yuppa DP, Carmona MA, Burstein HJ, Suzuki J, Nayak MM, Martins Y. Experts' perspectives on the role of medical marijuana in oncology: A semistructured interview study. Psychooncology. 2017 08; 26(8):1087-1092. PMID: 28040884.
    Citations:    Fields:    Translation:Humans
  9. Suzuki J, Valenti ES. Intentional Intra-arterial Injection of Heroin: A Case Report. J Addict Med. 2017 Jan/Feb; 11(1):77-79. PMID: 28027191.
    Citations:    Fields:    Translation:Humans
  10. Suzuki J, El-Haddad S. A review: Fentanyl and non-pharmaceutical fentanyls. Drug Alcohol Depend. 2017 Feb 01; 171:107-116. PMID: 28068563.
    Citations: 17     Fields:    Translation:Humans
  11. Welsh JW, Rodriguez C, Suzuki J. Bilateral Upper Extremity Cellulitis From Injecting Crack Cocaine Dissolved in Lemon Juice: A Case Report. Prim Care Companion CNS Disord. 2016 Oct 13; 18(5). PMID: 27835731.
    Citations:    Fields:    Translation:HumansAnimals
  12. Hardaway R, Schweitzer J, Suzuki J. Hallucinogen Use Disorders. Child Adolesc Psychiatr Clin N Am. 2016 Jul; 25(3):489-96. PMID: 27338969.
    Citations:    Fields:    Translation:Humans
  13. Suzuki J. Medication-assisted treatment for hospitalized patients with intravenous-drug-use related infective endocarditis. Am J Addict. 2016 Apr; 25(3):191-4. PMID: 26991660.
    Citations: 2     Fields:    Translation:Humans
  14. Dwyer-Clonts M, Frates E, Suzuki J. Managing Problem Drinking: Screening Tools and Brief Interventions for Primary Care Physicians. Am J Lifestyle Med. 2017 Nov-Dec; 11(6):424-429. PMID: 30202365.
    Citations:    
  15. Suzuki J, Dodds T. Clinician recommendation of 12-step meeting attendance and discussion regarding disclosure of buprenorphine use among patients in office-based opioid treatment. Subst Abus. 2016; 37(1):31-4. PMID: 26682722.
    Citations:    Fields:    Translation:Humans
  16. Rodriguez CP, Vaidya A, Tishler LW, Suzuki J. INTERACTIVE MEDICAL CASE. A Painful Subject. N Engl J Med. 2015 Dec 24; 373(26):e32. PMID: 26699187.
    Citations:    Fields:    Translation:Humans
  17. Mittal L, Suzuki J. Feasibility of collaborative care treatment of opioid use disorders with buprenorphine during pregnancy. Subst Abus. 2017 Jul-Sep; 38(3):261-264. PMID: 26672650.
    Citations:    Fields:    Translation:Humans
  18. Minen MT, Lindberg K, Wells RE, Suzuki J, Grudzen C, Balcer L, Loder E. Survey of Opioid and Barbiturate Prescriptions in Patients Attending a Tertiary Care Headache Center. Headache. 2015 Oct; 55(9):1183-91. PMID: 26316376; PMCID: PMC4757493.
    Citations: 1     Fields:    Translation:Humans
  19. Shu J, Huang H, Suzuki J. The Early-Career Consultation Psychiatrist: Leading the Integration of Substance Use Treatment Into the Primary Care Setting. Psychosomatics. 2015 Nov-Dec; 56(6):706-7. PMID: 26674483.
    Citations:    Fields:    Translation:Humans
  20. Suzuki J, Ellison TV, Connery HS, Surber C, Renner JA. Training in Buprenorphine and Office-Based Opioid Treatment: A Survey of Psychiatry Residency Training Programs. Acad Psychiatry. 2016 Jun; 40(3):498-502. PMID: 26017618.
    Citations:    Fields:    Translation:Humans
  21. Sivashanker K, Mufson M, Mittal L, Ross E, Suzuki J. Challenges in managing acute on chronic pain in a pregnant woman at high risk for opioid use disorder in the general hospital setting. Harv Rev Psychiatry. 2015 Mar-Apr; 23(2):157-66. PMID: 25747928.
    Citations: 1     Fields:    Translation:Humans
  22. Suzuki J, Zinser J, Klaiber B, Hannon M, Grassi H, Spinosa M, Ramirez A, Issa M, Chin Feman SP. Feasibility of Implementing Shared Medical Appointments (SMAs) for Office-Based Opioid Treatment With Buprenorphine: A Pilot Study. Subst Abus. 2015; 36(2):166-9. PMID: 25738320.
    Citations: 3     Fields:    Translation:Humans
  23. Suzuki J, DeVido J, Kalra I, Mittal L, Shah S, Zinser J, Weiss RD. Initiating buprenorphine treatment for hospitalized patients with opioid dependence: A case series. Am J Addict. 2014 Nov 06. PMID: 25376754.
    Citations:    
  24. Suzuki J, Dekker MA, Valenti ES, Arbelo Cruz FA, Correa AM, Poklis JL, Poklis A. Toxicities associated with NBOMe ingestion-a novel class of potent hallucinogens: a review of the literature. Psychosomatics. 2015 Mar-Apr; 56(2):129-39. PMID: 25659919.
    Citations: 3     Fields:    Translation:Humans
  25. Suzuki J, Poklis JL, Poklis A. "My friend said it was good LSD": a suicide attempt following analytically confirmed 25I-NBOMe ingestion. J Psychoactive Drugs. 2014 Nov-Dec; 46(5):379-82. PMID: 25364988.
    Citations: 1     Fields:    Translation:Humans
  26. Suzuki J, Connery HS, Ellison TV, Renner JA. Preliminary survey of office-based opioid treatment practices and attitudes among psychiatrists never receiving buprenorphine training to those who received training during residency. Am J Addict. 2014 Nov-Dec; 23(6):618-22. PMID: 25065457; PMCID: PMC4391742.
    Citations: 2     Fields:    Translation:Humans
  27. Suzuki J, Matthews ML, Brick D, Nguyen MT, Wasan AD, Jamison RN, Ellner AL, Tishler LW, Weiss RD. Implementation of a collaborative care management program with buprenorphine in primary care: a comparison between opioid-dependent patients and patients with chronic pain using opioids nonmedically. J Opioid Manag. 2014 May-Jun; 10(3):159-68. PMID: 24944066; PMCID: PMC4085743.
    Citations: 1     Fields:    Translation:Humans
  28. Huang H, Chan YF, Bauer AM, Suzuki J, Katon W, Russo J, Hogan D, Unützer J. Specialty behavioral health service use among chronically ill medicare advantage patients with substance use problems. Psychosomatics. 2013 Nov-Dec; 54(6):546-51. PMID: 23932530; PMCID: PMC3830673.
    Citations:    Fields:    Translation:Humans
  29. Isomura T, Suzuki J, Murai T. Paradise Lost: The relationships between neurological and psychological changes in nicotine-dependent patients. Addict Res Theory. 2014 Apr; 22(2):158-165. PMID: 24719610.
    Citations:    
  30. Suzuki J, Meyer F, Wasan AD. Characteristics of medical inpatients with acute pain and suspected non-medical use of opioids. Am J Addict. 2013 Sep-Oct; 22(5):515-20. PMID: 23952900.
    Citations:    Fields:    Translation:Humans
  31. Suzuki J, Mittal L, Woo SB. Sublingual buprenorphine and dental problems: a case series. Prim Care Companion CNS Disord. 2013; 15(5). PMID: 24511440; PMCID: PMC3907320.
    Citations:    Fields:    
  32. Suzuki J, Park EM. Buprenorphine/naloxone and dental caries: a case report. Am J Addict. 2012 Sep-Oct; 21(5):494-5. PMID: 22882403.
    Citations: 1     Fields:    Translation:Humans
  33. Park EM, Meltzer-Brody S, Suzuki J. Evaluation and management of opioid dependence in pregnancy. Psychosomatics. 2012 Sep-Oct; 53(5):424-32. PMID: 22902085.
    Citations: 2     Fields:    Translation:Humans
  34. Freedman JL, Crow FF, Gutheil TG, Sanchez LT, Suzuki J. Treating a physician patient with psychosis. Asian J Psychiatr. 2012 Jun; 5(2):193-8. PMID: 22813669.
    Citations:    Fields:    Translation:Humans
  35. Park EM, Suzuki J. Treatment of opioid dependence and cancer pain with sublingual buprenorphine: a case report. Am J Addict. 2012 May-Jun; 21(3):283-4. PMID: 22494234.
    Citations:    Fields:    Translation:Humans
  36. Suzuki J, Haimovici F, Chang G. Alcohol use disorders after bariatric surgery. Obes Surg. 2012 Feb; 22(2):201-7. PMID: 21188544.
    Citations: 32     Fields:    Translation:Humans
  37. Suzuki J, Chang G. Consultation to the medically ill: a survey of addiction psychiatry fellowship programs. Am J Addict. 2011 Sep-Oct; 20(5):476-7. PMID: 21838848; PMCID: PMC3156615.
    Citations:    Fields:    
  38. Suzuki J, Gitlin DF, Chang G. Survey of psychosomatic medicine fellowships: training in substance use disorders. Psychosomatics. 2011 May-Jun; 52(3):296-7. PMID: 21565606.
    Citations:    Fields:    Translation:Humans
  39. Suzuki J, Tyson JW. Misconceptions about the safety of ingesting methanol-based solid fuels: a case report. Prim Care Companion CNS Disord. 2011; 13(2). PMID: 21977352; PMCID: PMC3184589.
    Citations:    Fields:    
  40. Halpern JH, Suzuki J, Huertas PE, Passie T. Addiction Medicine: Science and Practice. Edited by Johnson BA. Hallucinogens. 2010; p1083-98.
  41. Renner JA & Suzuki J. Addiction Medicine: Science and Practice. Edited by Johnson BA. Opiates and prescription drugs. 2010; p463-94.
  42. Suzuki J. Handbook of office-based buprenorphine treatment of opioid dependence. Edited by Renner JA, Levounis P. Logistics of office-based opioid treatment with buprenorphine. 2010; pp 253-274.
  43. Halpern JH, Suzuki J, Huertas PE, Passie T. Encyclopedia of Psychopharmacology. Edited by Stolerman IP. Hallucinogen abuse and dependence. 2010; pp569-572.
  44. Suzuki J, Halpern JH, Passie T, Huertas PE. Pharmacology and Treatment of Substance Abuse: Evidence- and Outcome-Based Perspectives. Edited by Cohen LM, Collins FL, Young AM, McChargue DE, Leffingwell TR, Cook KL. Hallucinogens. 2009; pp319-418.
  45. Van Der Kolk BA, Burbridge JA, Suzuki J. The psychobiology of traumatic memory. Clinical implications of neuroimaging studies. Ann N Y Acad Sci. 1997 Jun 21; 821:99-113. PMID: 9238197.
    Citations: 9     Fields:    Translation:Humans
  46. van der Kolk BA, Burbridge JA, Suzuki J. Acta Neuropsychiatrica. Current status on the psychobiology of posttraumatic stress disorder. 1995; 7(S):34-37.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Suzuki's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (134)
Explore
_
Co-Authors (32)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH/NCATS Clinical and Translational Science Award (CTSA) program, grant number UL1TR001102, and through institutional support from Harvard University, Harvard Medical School, Harvard T.H. Chan School of Public Health, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Massachusetts General Hospital and the Dana Farber Cancer Institute.